What we do: AI-driven prenatal genetics company advancing whole-genome sequencing (WGS) for screening/diagnosis.
Flagship: Windrose—an AI/ML WGS reflex fetal test from maternal blood (no paternal DNA) from ~9–10 weeks.
Clinical scope: Detects inherited and de novo single-gene disorders across 113+ ACMG Tier-3 genes and hundreds more—far broader than current NIPT panels.
Evidence & sites: 160 PoC cases (US/Israel); moving into a 500–600 case U.S. multi-center validation; collaboration with 10 leading US Hospitals
Go-to-market: CLIA-lab partnerships.; BSaaS/licensing model to labs and hospitals.
Differentiation: Comprehensive gene coverage, early gestation, no paternal DNA, AI-powered pipeline.
Eyal Miller is currently associated with Identifai Genetics, leveraging his academic background in business and management. With an MBA and MA, he is poised to contribute to the company's growth and strategic initiatives.
Professional Experience
0y
Role Type
Industry
Organization Type
Career-Linked Companies in Finder
Companies from this member’s experience that have profiles in Finder